|
|
Article: Product launches, demographics drive internal analgesics market.(Industry Overview)
- Article from:
- Chain Drug Review
- Article date:
- January 1, 1996
CopyrightCOPYRIGHT 1996 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK - New products and old age have combined to make the internal analgesics market one of the healthiest and most competitive categories in the over-the-counter drug business.
With annual sales fast approaching the $3 billion mark, competitive pressures have spurred some of the largest marketing efforts yet in the category. At the same time, the trend toward self-medication and the aging of the population has had the effect of increasing the demand for effective pain relief products.
The most notable development in the category over the past two years has been the debut of Procter & Gamble & Co.'s (P&G's) Aleve. The product is an O-T-C version of ...